A recent study published in BMJ Global Health has revealed concerning findings about the World Health Organization’s private fundraising division, the WHO Foundation (WHOF). The research shows that the foundation has accumulated over $82.7 million in donations, with nearly half of this sum coming from untraceable sources.
According to the study, approximately 48% ($39.7 million) of the total donations consisted of anonymous contributions exceeding $100,000. The overall anonymous donation figure reaches 62.3% ($51.5 million) when including smaller contributions.
The Bill & Melinda Gates Foundation emerged as the largest identified donor among various contributors, which include prominent social media companies, medical device manufacturers, and entities from the banking and pharmaceutical sectors. Other notable donors include Meta, TikTok, Maybelline, Sanofi, Boehringer Ingelheim, and Novo Nordisk, who collectively pledged $50 million to the foundation.
The study highlights a troubling trend in the foundation’s operational structure, with the majority of funds – approximately 56% ($40 million) – being directed toward the WHOF’s own operational costs rather than WHO programs. Additionally, the foundation’s transparency ratings have deteriorated significantly since its establishment in 2020, dropping from a ‘B’ rating in its first year to a ‘D’ rating in subsequent reporting periods.
This decline in transparency is particularly evident in recent donation patterns, with nearly 80% of contributions in 2023 coming from anonymous sources in amounts exceeding $100,000. The foundation’s gift policy explicitly excludes only tobacco and firearms
manufacturers, leaving the door open for donations from controversial industries such as fossil fuels, alcohol producers, and vaping companies.
The timing of these revelations coincides with U.S. Health Secretary Robert F. Kennedy Jr.’s decision to reject the WHO’s proposed emergency powers treaty and withdraw funding from the Gates-backed vaccine alliance Gavi. Kennedy cited concerns about vaccine safety and criticized the alliance’s approach to public health priorities.
The foundation openly promotes its “unparalleled access to WHO” as a selling point for potential corporate partners, raising questions about potential conflicts of interest and undue influence on global health policies. Researchers from the London School of Hygiene and Tropical Medicine and University of Edinburgh, who conducted the study, warn that the foundation’s lack of transparency mirrors that of controversial “dark money” think tanks.
These findings raise significant concerns about the WHO’s ability to maintain neutrality in its decision-making processes, given its financial ties to pharmaceutical companies, technology firms facing censorship allegations, and substantial anonymous funding sources. The study suggests that this funding structure could potentially compromise the organization’s independence and credibility in global health governance.
The authors emphasize that the current level of donor transparency poses risks not only for potential undue influence but also for reputational damage to both the WHO Foundation and the World Health Organization itself. This situation has sparked debate about the need for greater accountability and transparency in global health funding mechanisms, particularly for organizations with significant influence over international health policies and practices.